Drug Shortage Report for MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL

Last updated on 2018-12-19 History
Report ID 23172
Drug Identification Number 02443902
Brand name MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL
Common or Proper name EMTRICITABINE/TENOFOVIR DISOPROXIL
Company Name MYLAN PHARMACEUTICALS ULC
Active Ingredient(s) TENOFOVIR DISOPROXIL FUMARATE EMTRICITABINE
Strength(s) 300MG 200MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30BT
ATC code J05AR
ATC description DIRECT ACTING ANTIVIRALS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2018-12-19
Actual start date
Estimated end date 2019-01-11
Actual end date 2018-12-18
Shortage status Avoided shortage
Updated date 2018-12-19
Company comments
Health Canada comments
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v96 2018-12-19 English Compare
v95 2018-12-12 French Compare
v94 2018-12-12 English Compare
v93 2018-12-11 French Compare
v92 2018-12-11 English Compare
v91 2018-12-05 French Compare
v90 2018-12-05 English Compare
v89 2018-11-21 English Compare
v88 2018-11-20 French Compare
v87 2018-11-20 English Compare
v86 2018-11-13 French Compare
v85 2018-11-13 English Compare
v84 2018-10-30 English Compare
v83 2018-10-29 French Compare
v82 2018-10-29 English Compare
v81 2018-10-25 English Compare
v80 2018-10-23 French Compare
v79 2018-10-23 English Compare
v78 2018-10-23 French Compare
v77 2018-10-23 English Compare

Showing 1 to 20 of 96